Chris Calabrese | LifeSci Advisors, IR |
Steven Shallcross | Chief Executive Officer & Chief Financial Officer |
Manel Cascallo | General Director of VCN & European Operations |
Frank Tufaro | Head of Operations of VCN |
Jim Molloy | Alliance Global Partners |
Jason McCarthy | Maxim Group |
Michael Okunewitch | Maxim Group |
Greetings and welcome to the Synthetic Biologics Fourth Quarter and Full Year 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn this conference over to your host, Mr.